Clickless DTx is the world’s first digital therapeutic solution dedicated to temporomandibular disorder (TMD), providing personalized treatment feedback through an AI-powered facial recognition system that analyzes patient movement.
Through a mobile application, patients can receive evidence-based self-care without hospital visits, with guided content including stretching, relaxation exercises, meditation, and pain tracking.
Clickless was designated as an Innovative Medical Device by the Korean Ministry of Food and Drug Safety in 2024 and is currently completing domestic exploratory and pivotal clinical trials.
Beyond Medicine aims to pioneer a new therapeutic paradigm in the dental and musculoskeletal digital therapeutics market through this groundbreaking solution.
